SCHEMBL2500804

SCHEMBL2500804

Cc1ccc(-c2nccnn2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.47
MEN1 O00255 3/20 0.47
NOTUM Q6P988 2/20 0.41
NISCH Q9Y2I1 1/20 0.41
ALDH1A1 P00352 1/20 0.40
NPC1 O15118 4/20 0.39
RAB9A P51151 4/20 0.39
CCNB2 O95067 1/20 0.39
CDK1 P06493 1/20 0.39
CCNB1 P14635 1/20 0.39
GSK3A P49840 1/20 0.39
GSK3B P49841 1/20 0.39
CDK5 Q00535 1/20 0.39
CDK5R1 Q15078 1/20 0.39
CCNB3 Q8WWL7 1/20 0.39
CLK4 Q9HAZ1 1/20 0.38
MAPT P10636 2/20 0.37
LMNA P02545 2/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19435586 0.91 CLK4 (0.38) KMT2AMEN1ALDH1A1NPC1RAB9A
SCHEMBL10731993 0.80 MAPT (0.46) KMT2AMEN1NOTUMNPC1RAB9A
SCHEMBL4303322 0.80 MEN1 (0.56) KMT2AMEN1NPC1RAB9ACCNB2
SCHEMBL27668598 0.79 CLK4 (0.66) KMT2AMEN1ALDH1A1NPC1RAB9A
SCHEMBL11840271 0.79 LMNA (0.42) KMT2AMEN1NISCHALDH1A1NPC1
SCHEMBL17701519 0.79 KIF11 (0.48) KMT2ANISCHALDH1A1NPC1RAB9A
SCHEMBL30186716 0.79 NPC1 (0.52) NOTUMALDH1A1NPC1RAB9APOLB
SCHEMBL6484311 0.79 NPC1 (0.52) NOTUMALDH1A1NPC1RAB9APOLB
SCHEMBL6181561 0.79 MAPT (0.46) KMT2AMEN1NOTUMNPC1RAB9A
SCHEMBL14656056 0.79 NPC1 (0.52) NOTUMALDH1A1NPC1RAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2370413-A1 MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2011-10-05 EP disclosed
WO-2010077275-A1 MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2010-07-08 WO disclosed